24 March 2022 : Clinical Research
Efficacy of PD-1 Inhibitor Combined with Bevacizumab in Treatment of Advanced Endometrial Cancer Patients with Mismatch Repair Deficiency (dMMR)/High-Level Microsatellite Instability (MSI-H)
Ying Liao1BCE, Changhua Zhu
DOI: 10.12659/MSM.934493
Med Sci Monit 2022; 28:e934493

Figure 1 Flow diagram demonstrating the patient selection process in this study. The figure was generated using Microsoft Word 2007 (Microsoft, Redmond, WA, USA).